Baxter (NYSE: BAX) reported Q2 EPS of $0.68, $0.02 better than the analyst estimate of $0.66. Revenue for the quarter came in at $3.81 billion versus the consensus estimate of $3.75 billion.

GUIDANCE:

Baxter sees Q3 2024 EPS of $0.77-$0.79, versus the consensus of $0.74.

Baxter sees FY2024 EPS of $2.93-$3.01, versus the consensus of $2.92.

For earnings history and earnings-related data on Baxter (BAX) click here.